Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Spectral Medical Inc > No volume and no liquidity
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(784)
•••
Comment by mercedesmanon Aug 29, 2022 9:49am
246 Views
Post# 34926364

RE:RE:RE:RE:RE:No volume and no liquidity

RE:RE:RE:RE:RE:No volume and no liquidity
Geery wrote:

Products/solutions seem great. Company/management is the roulette component. That is probably where Tech is highlighting. 

On the surface it looks like a no brainer. Internally I have no clue and very little confidence. Management have yet to prove themselves for my liking. There have been more positives lately but I just keep waiting for the next negative. 

 



Point earned and taken Geery.

Hopefully Seto has been cooking up something behind the scenes that is more creative, less dilutive, and doesn't reward non-performing parties like Paradigm or an opportunistic investor "in it" for the warrant play only.

The BoD has entrusted him to bring it home.  Let's hope he doesn't mess it up.  Some believe that any "dog with a note" could save this one, from penny-stock purgatory.

MM

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities